Americas

Pivotal study to evaluate Incyte’s IDO1 inhibitor in combination with Merck’s anti-PD-1 therapy in patients with advanced or metastatic melanoma...

Clinical trial to evaluate MacroGenics' Fc-optimized anti-HER2 antibody with Merck's anti-PD-1 therapy in patients with advanced HER2-positive gastric cancer MacroGenics,...

Following the successful closure of the merger with drug maker Ranbaxy, Dilip Shanghvi-led Sun Pharma said on Wednesday that it...

Sun Pharmaceutical Industries, India’s largest drugmaker, on Wednesday announced the closure of its merger with Ranbaxy Laboratories and said the...

Sun Pharmaceutical Industries is in the process of closing its merger with Ranbaxy. The former's chief financial officer (CFO), Uday...

Sun Pharmaceutical Industries LtdBSE -0.35 % has won US approval to buy Ranbaxy Laboratories LtdBSE -0.61 % on condition that...

Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that the U.S. Food and Drug Administration (FDA) has advised Collegium that it will...

one approved for use in arthritis and the other approved for cancer -- may also hold potential for boosting hair...

Allergan plc today announced that three data posters/presentations for eluxadoline will be presented during the American College of Gastroenterology 2015...